DiscoverAt the Intersection of Science and LawThe moral imperative: Balancing innovation, regulation and prescription drug availability
The moral imperative: Balancing innovation, regulation and prescription drug availability

The moral imperative: Balancing innovation, regulation and prescription drug availability

Update: 2022-03-21
Share

Description

DLA Piper's Jim Greenwood and Geoff Levitt are joined by Peter Kolchinsky, founding Partner and Portfolio Manager at RA Capital, to discuss the importance of – and complications in – balancing biopharmaceutical innovation, industry regulations and prescription drug availability.

See omnystudio.com/listener for privacy information.

Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

2024-11-1529:38

Life sciences companies and the risks posed by the mifepristone litigation

Life sciences companies and the risks posed by the mifepristone litigation

2023-05-1933:18

Trade secrets protection in the life sciences sector

Trade secrets protection in the life sciences sector

2023-04-1221:23

Cross-border considerations for privacy in clinical trials

Cross-border considerations for privacy in clinical trials

2023-02-0618:19

Global Life Sciences Supply Chain Insights

Global Life Sciences Supply Chain Insights

2022-11-0327:36

AI risk assessments: Future-proofing your innovation when rules can change mid-game

AI risk assessments: Future-proofing your innovation when rules can change mid-game

2022-09-0624:43

The rise of global telehealth

The rise of global telehealth

2022-06-0125:35

Advising the advisor: Tips for navigating the life sciences and regulatory environment

Advising the advisor: Tips for navigating the life sciences and regulatory environment

2022-04-1831:00

The moral imperative: Balancing innovation, regulation and prescription drug availability

The moral imperative: Balancing innovation, regulation and prescription drug availability

2022-03-2130:31

Incentivizing diverse representation in clinical trials

Incentivizing diverse representation in clinical trials

2022-03-0222:40

The crossroad of science and law

The crossroad of science and law

2021-12-1626:17

Social media’s impact on the life sciences industry

Social media’s impact on the life sciences industry

2021-11-0834:50

Understanding AI and its use in drug discovery

Understanding AI and its use in drug discovery

2021-10-0531:49

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

2021-09-0326:25

Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The moral imperative: Balancing innovation, regulation and prescription drug availability

The moral imperative: Balancing innovation, regulation and prescription drug availability

DLA Piper